Group 1 - Huatai Securities and Northeast Securities have received approval from the China Securities Regulatory Commission (CSRC) for the establishment and capital increase of their Hong Kong subsidiaries, marking a significant step in the internationalization of China's securities industry [1][2] - Huatai Securities will increase its capital in its wholly-owned subsidiary, Huatai Jin控, by HKD 500 million, raising its registered capital from HKD 480 million to nearly HKD 1 billion [1] - Northeast Securities has been approved to use its own funds to establish Dongzheng International Financial Holdings Limited with an investment of HKD 500 million, which will serve as its first overseas business platform [1][2] Group 2 - The successful approvals of these two mid-sized securities firms are part of the CSRC's strategy to build internationally competitive large financial institutions during the 14th Five-Year Plan period [2] - As of mid-2025, mainland securities firms have established 36 overseas subsidiaries, primarily in Hong Kong, with total assets reaching HKD 1.64 trillion, a year-on-year increase of over 20% [2] - Leading firms like CICC and CITIC Securities have seen their international business revenue ratios reach 31% and 21%, respectively, and hold significant positions in the Hong Kong IPO market [2] Group 3 - Securities firms are diversifying their internationalization strategies beyond traditional brokerage services, with many exploring wealth management and asset management innovations [3] - CITIC Securities has established a comprehensive service platform covering the Asia-Pacific region, achieving a doubling of overseas wealth management product sales in the first half of 2025 [3] - The increasing demand for RMB assets globally and the deepening globalization of Chinese enterprises highlight the importance of providing high-quality cross-border financial services as a key factor for enhancing core competitiveness [3]

Core Viewpoint - Huatai Securities and Northeast Securities have received regulatory approval for their Hong Kong subsidiaries, marking a significant step in the internationalization of mid-sized Chinese brokerage firms [1][2]. Group 1: Company Developments - Huatai Securities has been approved to increase its capital in its wholly-owned Hong Kong subsidiary, Huatai Jin控, by HKD 500 million, raising its registered capital to nearly HKD 1 billion [1]. - Northeast Securities has been authorized to establish a new offshore platform, Dongzheng International Financial Holdings, with its own funds of HKD 500 million, marking its first overseas operational entity [2]. - Both companies are part of the first batch of mid-sized brokerages to receive approval for overseas subsidiaries since the China Securities Regulatory Commission's (CSRC) 2025 plan to develop influential international institutions [1][2]. Group 2: Financial Performance - Huatai Securities reported a total revenue of CNY 5.064 billion for 2025, a year-on-year increase of 30.94%, and a net profit of CNY 2.104 billion, up 41.64% [1]. - Northeast Securities anticipates a net profit of CNY 1.477 billion for 2025, reflecting a 69.06% increase compared to the previous year [2]. Group 3: Industry Trends - The internationalization of brokerage firms is expanding beyond leading institutions to include mid-sized firms, driven by regulatory support and market demand [6]. - The total assets of overseas subsidiaries of mainland securities firms reached HKD 1.64 trillion by mid-2025, with a year-on-year growth of 20.45% [4]. - Chinese brokerages are increasingly dominating the Hong Kong IPO market, with the top ten underwriting institutions holding a combined market share of 72%, half of which are Chinese brokerages [4]. Group 4: Strategic Implications - The approval of Hong Kong subsidiaries for mid-sized brokerages signals a shift in the competitive landscape, as these firms transition from domestic competitors to active participants in the global financial services network [6]. - The internationalization of brokerage services is becoming essential, with the demand for cross-border services and the global allocation of RMB assets rising [6].

■周尚伃 近日，东北证券获批设立香港子公司、华安证券增资香港子公司获证监会无异议复函、华泰证券百亿港元H股可转债顺利 落地，三件行业大事同日落定，中资券商"走出去"正从单点突破迈向全面提速。 笔者认为，通过上述三家券商在国际业务上取得的新进展可以看出，当前中资券商国际化呈现出清晰的战略转型路径：以 中国香港为核心枢纽，头部券商加速资本扩容，中小券商密集补位入场。券商行业国际业务发展正从"有没有"的基础布局，稳 步迈向"强不强"的质量提升阶段。 首先，锚定中国香港枢纽，密集"落子"补齐国际业务短板。作为连接内地与全球市场的"超级联系人"，中国香港始终是券 商国际化的首选阵地。此次，东北证券获准以自有资金出资5亿港元设立子公司，一举补齐了国际业务牌照短板，迈出国际 化"从0到1"的关键一步。对于区域券商而言，在中国香港设立的子公司不只是开展跨境经纪、投行、资管等业务的运营主体， 更是服务企业跨境融资、对接全球资本、搭建跨境资产配置平台的核心通道。 最后，凭借创新资本工具，为国际业务拓展更大空间。在创新资本工具应用方面，头部券商更加"得心应手"。华泰证券从 2月3日发布发行议案，到2月10日顺利完成发行，百亿港元H ...

2月10日，华泰证券宣布发布100亿港元H股可转债，以支持境外业务发展。同一时间，华安证券5亿港元增 资香港全资子公司、东北证券5亿港元设立香港子公司事项，双双拿到了中国证监会的无异议函。 2025年，伴随全球资本市场交投活跃，中资券商对境外业务的落子布局动作也按下加速键。进入2026年不到两 个月，广发证券和华泰证券就已相继完成了61亿港元和100亿港元的H股再融资，募得资金也均计划用于强化 境外业务布局。 有分析师指出，当前券商海外业务处于高景气阶段，国际子公司资本利用效率更快，ROE高于国内业务、杠杆 上限更高。在此背景下，上市券商争先加码国际业务，有望进一步对业绩贡献增量，并助力中期ROE提升。 三家券商同日加码 2月10日晚间， 华泰证券披露， 此前公告拟发行的2027年到期、本金总额100亿港元的H股零息可转换债券， 其认购协议项下所有先决条件均已达成，并于当日完成发行，该债券将在维也纳证券交易所运营的Vienna MTF挂牌上市。 根据公告，此次债券发行完成后，华泰证券募集资金净额估计约为99.25亿港元，将用于境外业务发展及补充 营运资金。华泰证券认为，这将有助于增强其对国际市场风险及挑战的应 ...

东北证券股份有限公司 2026 年面向专业投资者公开发行 短期公司债券跟踪评级报告 1 www.lhratings.com 联合〔2026〕929 号 联合资信评估股份有限公司通过对东北证券股份有限公司主体 及其相关债券的信用状况进行跟踪分析和评估，确定维持东北证券 股份有限公司主体长期信用等级为 AAA，维持"25 东北 D4"和"25 东北 D5"信用等级为 A-1，评级展望为稳定。 特此公告 联合资信评估股份有限公司 评级总监： 二〇二六年二月十一日 跟踪评级报告 | 2 声 明 一、本报告是联合资信基于评级方法和评级程序得出的截至发表之日 的独立意见陈述，未受任何机构或个人影响。评级结论及相关分析为联合 资信基于相关信息和资料对评级对象所发表的前瞻性观点，而非对评级对 象的事实陈述或鉴证意见。联合资信有充分理由保证所出具的评级报告遵 循了真实、客观、公正的原则。鉴于信用评级工作特性及受客观条件影响， 本报告在资料信息获取、评级方法与模型、未来事项预测评估等方面存在 局限性。 二、本报告系联合资信接受东北证券股份有限公司（以下简称"该公 司"）委托所出具，除因本次评级事项联合资信与该公司构成评级委托关 ...

Group 1 - The core point of the article is that Northeast Securities has received approval from the China Securities Regulatory Commission (CSRC) to establish its wholly-owned subsidiary, Dongzheng International Financial Holdings Limited, in Hong Kong, marking a significant step in its internationalization strategy [1][3][4] - Dongzheng International will serve as an important platform for Northeast Securities to expand its international business, with an initial investment of 500 million HKD [1][4] - The establishment of a Hong Kong subsidiary is seen as a crucial part of the internationalization process for mainland securities firms, especially in light of the increasing activity in the Hong Kong stock market and adjustments in the A-share IPO schedule [1][4][10] Group 2 - The approval signifies that Northeast Securities' internationalization efforts have entered a substantive phase, with other firms like First Capital and Western Securities also working on establishing their Hong Kong subsidiaries [2][11] - The business scope of Dongzheng International will include financial and related services, while explicitly prohibiting activities unrelated to finance, lending, or direct operations within mainland China [4][5] - The establishment of the subsidiary is part of Northeast Securities' strategy to seek new growth points, especially as its recent performance has been relatively stable, with a projected net profit of 1.477 billion CNY for 2025, representing a year-on-year increase of 69.06% [6][7][9] Group 3 - The competitive landscape in Hong Kong is challenging, with many mainland securities firms already having established subsidiaries, including major players like CITIC Securities and Huatai Securities, making it essential for Northeast Securities to establish its presence [10][13] - Other firms are also planning to set up Hong Kong subsidiaries, indicating a trend among mainland brokers to expand their international footprint [11][12] - The competition in the Hong Kong market is intense, with both local and international firms, leading to pressure on profit margins as firms may opt to "compress profits to capture market share" [13]

Core Insights - The article discusses the paradox of significant profits from the STAR Market investments while several brokerage firms are simultaneously reducing capital in their alternative investment subsidiaries [1] Group 1: Brokerage Firms' Actions - Dongxing Securities announced a capital reduction of 300 million yuan in its alternative investment subsidiary, Dongxing Investment [1] - At least five brokerage firms have announced capital reductions for their alternative investment subsidiaries since 2025, primarily involving smaller firms such as Dongxing Securities, Zhongshan Securities, Guodu Securities, Northeast Securities, and Zhongyuan Securities [1] - The capital reduction is viewed as a strategic adjustment aimed at improving overall capital efficiency [1] Group 2: STAR Market Investment Performance - In 2025, brokerage firms achieved substantial floating profits from STAR Market investments, with a total scale of 1.121 billion yuan in IPO follow-on investments, resulting in floating profits of 3.065 billion yuan [1] - The profits from STAR Market investments are highly concentrated among leading brokerage firms, with CITIC Securities alone participating in 8 out of 19 IPO projects in 2025 [1] Group 3: Challenges for Smaller Brokerages - Smaller brokerages face significant net capital pressure and liquidity risks due to the STAR Market follow-on investment requirements, which mandate a follow-on ratio of 2% to 5% and a 24-month lock-up period [1] - This makes it challenging for smaller brokerages to benefit from the lucrative STAR Market investments [1]

Core Viewpoint - Jiangsu Benchuan Intelligent Circuit Technology Co., Ltd. has received approval from the Shenzhen Stock Exchange's Listing Review Committee for its issuance of convertible bonds, which will raise up to 469 million yuan for various projects and working capital [1][2]. Group 1: Fundraising Details - The total amount to be raised from the issuance of convertible bonds is not more than 46,900,000 yuan, which will be allocated to specific projects and working capital [1]. - The projects funded by the raised capital include: - Zhuhai Shuo Hong's annual production of 300,000 square meters of intelligent circuit products, with a total investment of 356.19 million yuan and planned funding of 334.54 million yuan [2]. - Benchuan Intelligent's PCB production base in Thailand, with a total investment of 237.58 million yuan and planned funding of 105.46 million yuan [2]. - Supplementing working capital with an investment of 29 million yuan [2]. - The total investment for all projects is 622.77 million yuan, with the raised funds covering 46.9 million yuan [2]. Group 2: Issuance and Underwriting - The convertible bonds will be convertible into the company's A-shares and will be listed on the Shenzhen Stock Exchange [2]. - The issuance method will be determined by the board of directors and/or authorized personnel in consultation with the sponsor (lead underwriter) according to relevant laws and regulations [2]. - The lead underwriter for this issuance is Northeast Securities Co., Ltd., with representatives Wang Dandan and Hang Lijun [3]. Group 3: Company Background - Benchuan Intelligent was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on August 5, 2021, raising a total of 621 million yuan, with a net amount of 561 million yuan after deducting issuance costs [3]. - The company initially planned to raise 374 million yuan for projects including the expansion of high-frequency, high-speed, multi-layer, and high-density PCB production lines, as well as R&D center construction and working capital [3].

Group 1 - Yunnan Baiyao plans to invest 137 million yuan in the second phase of its oral liquid project to meet growing market demand for its products [1] - Hanma Technology's subsidiary intends to increase capital by 575 million yuan in Shanghai Suoda and transfer 100% of its shares for 485 million yuan [2] - JiaoKong Technology won a contract worth 16.8 million euros for a project in Turkey, expected to be operational by December 2028 [3] Group 2 - Hanhui Technology's shareholder plans to reduce their stake by up to 1.86% [4] - Haisheng Pharmaceutical reported a 32.72% increase in revenue and a 36.89% increase in net profit for 2025 [5] - Oukang Pharmaceutical's net profit for 2025 decreased by 48.21% despite a 7.73% increase in revenue [6] Group 3 - Huaihe Energy expects a net profit of 1.684 to 1.784 billion yuan for 2025, a year-on-year increase of 96.31% to 107.97% [7] - Watson Bio received approval for clinical trials of its varicella vaccine [8] - ShunNa Co. plans to reduce its stake by up to 1% [9] Group 4 - Chutianlong intends to raise up to 760 million yuan through a private placement [10] - Yifang Technology's shareholders plan to reduce their holdings by up to 34,830 shares [12] - Yunjigroup's subsidiary signed an EPC contract worth 1.331 billion yuan [13] Group 5 - Jianghuai Automobile reported a 2.14% decrease in January sales [15] - Lifan Pharmaceutical participated in a national procurement program and aims to be selected for three products [16] - Magu Technology's shareholder plans to reduce their stake by up to 3% [17] Group 6 - Jianghuai Automobile's private placement raised approximately 3.5 billion yuan, with investor Ge Weidong subscribing for 1 billion yuan [18] - Huichuan Technology expects a net profit increase of 16% to 26% for 2025 [19] - Hezhong China reported a 10.24% decrease in January consolidated revenue [20] Group 7 - Zhongjian Technology plans to invest 30 million yuan in a new fund focused on new energy [22] - Kanda New Materials intends to invest 646 million yuan in a new production project [23] - Yuegui Co.'s subsidiary obtained a mining license [25] Group 8 - TBG Technology plans to invest 1.53 billion yuan in a new project [27] - Xiexin Integration stated it currently lacks production capacity in the "space photovoltaic" sector [28] - Shibao Testing's controlling shareholder plans to transfer 8.5% of the company's shares [29] Group 9 - TeBao Bio reported a 31.18% increase in revenue and a 25.39% increase in net profit for 2025 [30] - Guoke Tiancai reported a 14.73% increase in revenue and a 17.94% increase in net profit for 2025 [31] - Miaokelando signed a memorandum with SADAFCO to explore the children's cheese snack market in Saudi Arabia [32] Group 10 - Tangrenshen reported a 25.6% decrease in January sales revenue [33] - Northeast Securities received approval to establish a subsidiary in Hong Kong [34] - Yiyi Co. terminated its asset acquisition plan due to changes in the target company's performance [35] Group 11 - Wushang Group's major shareholder plans to reduce their stake by up to 3% [36] - Weigang Technology's shareholder plans to reduce their stake by up to 2.98% [37] - Yutong Technology plans to acquire 51% of Huayan Technology for 449 million yuan [38] Group 12 - Huasan Pharmaceutical's shareholder plans to reduce their stake by up to 3% [39] - Runbei Hangke's major shareholder plans to reduce their stake by up to 3% [41] - Huada Technology plans to acquire 100% of Huayi Microelectronics for 2.996 billion yuan [42] Group 13 - ST Lifang's stock will resume trading after completing self-inspection work [43]

Group 1 - The core viewpoint is that AI+AR glasses are expected to surpass AI shooting glasses in market share by 2028, capturing nearly two-thirds of the market due to continuous technological updates and decreasing costs [1] - The current mainstream product is AI shooting glasses, with projected sales increasing from 5.5 million units in 2025 to 7 million units, and from 11 million units in 2026 to 18 million units [1] - The AI glasses market is anticipated to reach a scale of 149.996 billion yuan by 2030, with AI+AR glasses expected to meet both vision correction and display needs [1] Group 2 - Major tech companies like Meta and Alibaba are actively developing AI+AR glasses, with Meta's RayBan Display receiving positive market feedback, leading to a focus on fulfilling U.S. orders first [2] - Quark's AI glasses S1 have been well-received, prompting the addition of an assembly line to meet production demands [2] - Leading tech firms including Google, Amazon, Apple, and ByteDance plan to launch multiple AI glasses by 2026-2027, further validating the trend towards AI+AR glasses becoming mainstream [2] Group 3 - The potential user base for AI glasses is expanding from traditional glasses users to those with normal vision, with a focus on meeting both vision correction and display functionalities [3] - Companies like Quark, Rokid, and XREAL have established numerous offline experience stores, emphasizing the importance of traditional glasses users in their strategies [3] Group 4 - The integration challenges of waveguide and refractive lenses need to be addressed, with Rokid and Quark employing different solutions to tackle structural inconsistencies [4] - The one-piece bonding solution is expected to become the mainstream choice for integrating waveguide and refractive lenses, although it presents optical and customization challenges [4]